Procedures, dossier requirements, pharmacovigilance, policy
Marketing authorisation, reporting adverse events, production, distribution
Our story, our work, the organisation, working at the MEB, contact
02-01-2023 | 08:00
With effect from 1 January 2023, the Medicines Evaluation Board (MEB) will be increasing the fees for authorisation applications, ...
29-12-2022 | 12:15
Prior to the introduction of theĀ Veterinary Medicinal Products Regulation, antimycotics (antifungal agents) and antiprotozoal ...
29-12-2022 | 12:00
With effect from 1 January 2023, the Medicines Evaluation Board (MEB) will be increasing the fees. The fees of the Veterinary ...
07-12-2022 | 14:15
A significant portion of the potential anticancer medicines that reach the clinical phase do not make it to registration. This is ...
06-10-2022 | 16:30
The Veterinary Medicinal Products Unit has set in motion a number of changes to the sending, communicating and publishing letters ...
16-08-2022 | 10:00
As from 1 October, the Veterinary Medicinal Products Unit will no longer send marketing authorisations in hard copy. We ask all ...